FR167344 free base 

Binding assays for the B1 and B2 receptor are carried out by using [³H]des-Arg10-kallidin and [³H]bradykinin, respectively. Cell membranes (12.5-75 mg/mLl) are incubated with various concentrations (saturation experiments) or 500 pM (displacement experiments) of [³H]des-Arg10-kallidin or [³H]bradykinin for 90 min in 0.25 mLof the binding solution containing 20 mM HEPES, pH 7.4, 125 mM N-methyl-D-glucamine, 5 mM KCl, 0.1% BSA, 1 mM 1,10-phenanthrolin monohydrate, 1 mM dithiothreitol, 1 mM captopril and 140 mg/mLbacitracin (for the B1 receptor) or 25 mM trimethylaminoethanesulfonic acid, pH 6.8, 0.1% BSA, 1 mM 1,10-phenanthrolin monohydrate, 1 mM dithiothreitol, 1 mM captopril, and 140 mg/mLbacitracin (for the B2 receptor). All experiments are carried out at least three times in duplicate. The specific binding is calculated by subtracting the nonspecific binding, determined in the presence of 1 mM unlabeled des-Arg10-kallidin (for the B1 receptor) or bradykinin (for the B2 receptor), from the total binding. The specific binding activity amounted to 90–92% of the total binding activity^[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Rat: Male Sprague-Dawley rats (8 weeks old) are deprived of food overnight and treated orally with FR167344, 15 min before carrageenin is injected into the right hind paw intraplantar. Paw volume is measuredby water plethysmometer before and 1, 2, 3 and 4 h afterthe injection of carrageenin. FR167344 is dissolved in 0.05N HCl and administered orally at a volume of 5 mL/kg. Carrageenin is made up as 1% solution in saline. Each rat received 0.1 mL of the irritant. As saline-control, saline is administered in the same manner as carrageenin.

Mouse: Male ICR mice (Slc:ICR, 5 weeks old) are fasted overnight and used. Writhing responses are induced by an intraperitoneal injection of kaolin(250 mg/kg, 50 mL/kg). The responses are counted over a 10 or 15 min period by a trained observer. FR167344 dissolved in 0.05N HCl or vehicle (10 mL/kg) is administered orally 30 min before the intraperitoneal injection of kaolin. As saline-control, saline is administered in the same manner as kaolin^[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

• [1]. Aramori I, et al. Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657. Mol Pharmacol. 1997 Feb;51(2):171-6.  [Content Brief]

  [2]. Asano M, et al. Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivoanimal models of inflammation.Br J Pharmacol. 1997 Dec;122(7):1436-40.  [Content Brief]